Wren Capital LLP is a UK-based private equity firm focusing on technology-driven sectors. Their investment portfolio spans software, semiconductors, medical devices, and satellite technologies. While specific investment sizes are not disclosed, Wren Capital typically participates in Series A funding rounds.
The firm's portfolio includes Momentum Bioscience, a company developing innovative diagnostic solutions for sepsis and bloodstream infections. Wren Capital's investment approach emphasizes supporting cutting-edge technologies with potential for significant market impact. Their expertise in diverse tech sectors positions them to provide valuable insights and support to portfolio companies beyond financial investment.
Wren Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.